Swissmedic – Talk Bio

Actionable Insights Powered by AI

Novartis Gains World-First Approval of Malaria Treatment for Babies

4 days ago talkbio0Tagged Africa, Approved, artemether-lumefantrine, Coartem, Infant, Infant, Newborn, Malaria, Novartis, Swissmedic, venture

Novartis; malaria; Coartem Baby; Swissmedic; newborns; infants; Africa; approval; artemether-lumefantrine; Medicines for Malaria Venture; not-for-profit